Consistent with the previous reports, MEF2C was detected as an upstream factor in the pathway analysis of genes activated in TAC model, and the activation was indicated to be mediated by GATA4 activation and HDAC inhibition. The gene discussed is MEF2C; the disease is persistent truncus arteriosus.